Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University of Basel, Basel, Switzerland; Department of Genetics and Genome Biology, University of Leicester, Leicester, UK.
Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland; Department of Ophthalmology, University of Basel, Basel, Switzerland.
Am J Hum Genet. 2024 Apr 4;111(4):701-713. doi: 10.1016/j.ajhg.2024.03.001. Epub 2024 Mar 25.
Copy-number variants (CNVs) play a substantial role in the molecular pathogenesis of hereditary disease and cancer, as well as in normal human interindividual variation. However, they are still rather difficult to identify in mainstream sequencing projects, especially involving exome sequencing, because they often occur in DNA regions that are not targeted for analysis. To overcome this problem, we developed OFF-PEAK, a user-friendly CNV detection tool that builds on a denoising approach and the use of "off-target" DNA reads, which are usually discarded by sequencing pipelines. We benchmarked OFF-PEAK on data from targeted sequencing of 96 cancer samples, as well as 130 exomes of individuals with inherited retinal disease from three different populations. For both sets of data, OFF-PEAK demonstrated excellent performance (>95% sensitivity and >80% specificity vs. experimental validation) in detecting CNVs from in silico data alone, indicating its immediate applicability to molecular diagnosis and genetic research.
拷贝数变异(CNVs)在遗传性疾病和癌症的分子发病机制以及正常人类个体间变异中起着重要作用。然而,它们在主流测序项目中,尤其是外显子组测序中,仍然很难识别,因为它们通常发生在未针对分析的 DNA 区域。为了克服这个问题,我们开发了 OFF-PEAK,这是一种用户友好的 CNV 检测工具,它基于去噪方法和使用“非靶向”DNA 读取,这些读取通常被测序管道丢弃。我们在针对 96 个癌症样本的靶向测序数据以及来自三个不同人群的 130 个遗传性视网膜疾病个体的外显子组数据上对 OFF-PEAK 进行了基准测试。对于这两组数据,仅使用计算机数据,OFF-PEAK 在检测 CNV 方面表现出出色的性能(>95%的敏感性和>80%的特异性与实验验证相比),表明其可立即应用于分子诊断和遗传研究。